New Age Alpha Advisors LLC Purchases Shares of 32,790 Balchem Co. (NASDAQ:BCPC)

New Age Alpha Advisors LLC acquired a new position in Balchem Co. (NASDAQ:BCPC) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 32,790 shares of the basic materials company’s stock, valued at approximately $5,345,000.

Other institutional investors have also modified their holdings of the company. Westside Investment Management Inc. acquired a new position in Balchem in the third quarter worth approximately $27,000. R Squared Ltd acquired a new position in shares of Balchem in the 4th quarter worth $29,000. Wilmington Savings Fund Society FSB acquired a new position in shares of Balchem in the 3rd quarter worth $35,000. Venturi Wealth Management LLC acquired a new stake in shares of Balchem during the fourth quarter worth $95,000. Finally, Smartleaf Asset Management LLC boosted its position in shares of Balchem by 230.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company’s stock valued at $106,000 after purchasing an additional 450 shares during the period. Institutional investors and hedge funds own 87.91% of the company’s stock.

Balchem Stock Down 1.4 %

Shares of Balchem stock opened at $163.79 on Friday. Balchem Co. has a 12-month low of $137.69 and a 12-month high of $186.03. The stock has a market capitalization of $5.33 billion, a P/E ratio of 41.68, a PEG ratio of 4.41 and a beta of 0.63. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. The stock has a 50 day moving average price of $165.26 and a two-hundred day moving average price of $169.23.

Balchem (NASDAQ:BCPC) last posted its earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.11 by ($0.08). The firm had revenue of $240.00 million during the quarter, compared to analyst estimates of $239.96 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. Equities analysts expect that Balchem Co. will post 4.64 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on BCPC. StockNews.com downgraded Balchem from a “buy” rating to a “hold” rating in a report on Tuesday, February 25th. Sidoti upgraded shares of Balchem to a “hold” rating in a report on Tuesday, February 25th. Finally, HC Wainwright reissued a “buy” rating and set a $190.00 target price on shares of Balchem in a research note on Monday, February 24th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.